HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
HealthEquity Stock Up 1.4 %
Shares of HQY stock traded up $1.60 during midday trading on Wednesday, reaching $114.10. 826,779 shares of the stock were exchanged, compared to its average volume of 749,222. The firm has a market cap of $9.89 billion, a PE ratio of 104.67, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company’s 50 day moving average is $101.40 and its two-hundred day moving average is $90.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $114.60.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the company posted $0.40 earnings per share. On average, equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.
Institutional Investors Weigh In On HealthEquity
Wall Street Analysts Forecast Growth
Several research firms recently commented on HQY. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Finally, Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $110.71.
Get Our Latest Research Report on HQY
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What is a Secondary Public Offering? What Investors Need to Know
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Do ETFs Pay Dividends? What You Need to Know
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.